DK154287A - Substituerede oxadiazol-derivater, fremgangsmaade til fremstilling deraf og mellemprodukter til brug ved fremgangsmaaden samt laegemiddel indeholdende oxadiazolerne - Google Patents
Substituerede oxadiazol-derivater, fremgangsmaade til fremstilling deraf og mellemprodukter til brug ved fremgangsmaaden samt laegemiddel indeholdende oxadiazolerneInfo
- Publication number
- DK154287A DK154287A DK154287A DK154287A DK154287A DK 154287 A DK154287 A DK 154287A DK 154287 A DK154287 A DK 154287A DK 154287 A DK154287 A DK 154287A DK 154287 A DK154287 A DK 154287A
- Authority
- DK
- Denmark
- Prior art keywords
- oxadiazoles
- intermediates
- procedures
- procedure
- production
- Prior art date
Links
- 238000000034 method Methods 0.000 title 2
- FRYPWUYDPUBMRU-UHFFFAOYSA-N 2-[(4-chlorophenoxy)methyl]-5-(2,4-dichloro-5-fluorophenyl)-1,3,4-oxadiazole Chemical compound C1=C(Cl)C(F)=CC(C=2OC(COC=3C=CC(Cl)=CC=3)=NN=2)=C1Cl FRYPWUYDPUBMRU-UHFFFAOYSA-N 0.000 title 1
- 239000000543 intermediate Substances 0.000 title 1
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical class C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868607713A GB8607713D0 (en) | 1986-03-27 | 1986-03-27 | Oxadiazoles |
| GB868630896A GB8630896D0 (en) | 1986-12-24 | 1986-12-24 | Oxadiazoles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK154287D0 DK154287D0 (da) | 1987-03-26 |
| DK154287A true DK154287A (da) | 1987-09-28 |
Family
ID=26290549
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK154287A DK154287A (da) | 1986-03-27 | 1987-03-26 | Substituerede oxadiazol-derivater, fremgangsmaade til fremstilling deraf og mellemprodukter til brug ved fremgangsmaaden samt laegemiddel indeholdende oxadiazolerne |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5686463A (fr) |
| EP (1) | EP0239309B1 (fr) |
| JP (1) | JPH0784466B2 (fr) |
| KR (1) | KR870008883A (fr) |
| CN (1) | CN87102972A (fr) |
| AU (1) | AU603564B2 (fr) |
| DE (1) | DE3788739T2 (fr) |
| DK (1) | DK154287A (fr) |
| ES (1) | ES2061489T3 (fr) |
| FI (1) | FI871325A7 (fr) |
| HU (1) | HUT51617A (fr) |
| IL (1) | IL81930A0 (fr) |
| NO (1) | NO169439C (fr) |
| NZ (1) | NZ219646A (fr) |
| PT (1) | PT84533B (fr) |
| YU (1) | YU46688B (fr) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4837241A (en) * | 1986-09-08 | 1989-06-06 | A/S Ferrosan | Lipophillically-substituted piperidine oxadiazolyl compounds and their use in stimulating cognitive functions |
| US5043345A (en) * | 1989-02-22 | 1991-08-27 | Novo Nordisk A/S | Piperidine compounds and their preparation and use |
Families Citing this family (74)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8528633D0 (en) * | 1985-11-21 | 1985-12-24 | Beecham Group Plc | Compounds |
| AU620783B3 (en) * | 1986-06-27 | 1992-01-09 | Beecham Group Plc | 1,2,4-oxadiazolyl-azabicyclo compounds |
| GB8615785D0 (en) * | 1986-06-27 | 1986-08-06 | Beecham Group Plc | Compounds |
| ES2061502T3 (es) * | 1986-06-27 | 1994-12-16 | Beecham Group Plc | Nuevos n-heterociclos biciclicos puenteados. |
| AU614513B2 (en) * | 1987-04-15 | 1991-09-05 | Beecham Group Plc | 1-azabicyclic compounds |
| GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
| GB8717446D0 (en) * | 1987-07-23 | 1987-08-26 | Merck Sharp & Dohme | Chemical compounds |
| US5405853A (en) * | 1987-09-10 | 1995-04-11 | Merck Sharpe & Dohme Ltd. | Thiadiazoles useful in the treatment of senile dementia |
| NZ226000A (en) * | 1987-09-10 | 1991-06-25 | Merck Sharp & Dohme | Oxadiazolyl-azabicycloheptanes and pharmaceutical compositions |
| EP0307141B1 (fr) * | 1987-09-10 | 1993-01-13 | MERCK SHARP & DOHME LTD. | Oxazoles et thiazoles pour le traitement de la démence sénile |
| NZ225999A (en) * | 1987-09-10 | 1992-04-28 | Merck Sharp & Dohme | Azacyclic- or azabicyclic-substituted thiadiazole derivatives and pharmaceutical compositions |
| IL88156A (en) * | 1987-11-13 | 1997-02-18 | Novo Nordisk As | Azacyclic compounds their preparation and pharmaceutical compositions containing them |
| EP0322182A3 (fr) * | 1987-12-22 | 1992-01-02 | Beecham Group Plc | Composés azabicycliques, procédé pour leur préparation et compositions pharmaceutiques les contenant |
| EP0322034A3 (fr) * | 1987-12-22 | 1991-01-02 | Merck Sharp & Dohme Ltd. | Tétrahydropyridylméthyl oxadiazoles |
| IL88846A0 (en) * | 1988-01-08 | 1989-07-31 | Merck Sharp & Dohme | Lipophilic oxadiazoles,their preparation and pharmaceutical compositions containing them |
| NZ227684A (en) * | 1988-01-30 | 1991-07-26 | Merck Sharp & Dohme | Pyrazine, pyridazine, and pyrimidine derivatives and pharmaceutical compositions |
| NZ227841A (en) * | 1988-02-12 | 1991-08-27 | Merck Sharp & Dohme | Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions |
| GB8808433D0 (en) * | 1988-04-11 | 1988-05-11 | Merck Sharp & Dohme | Therapeutic agents |
| GB8808926D0 (en) * | 1988-04-15 | 1988-05-18 | Beecham Group Plc | Novel compounds |
| DK162892C (da) * | 1988-07-04 | 1992-05-11 | Novo Nordisk As | 1,2,5,6-tetrahydropyridinforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende disse |
| GB8816299D0 (en) * | 1988-07-08 | 1988-08-10 | Merck Sharp & Dohme | Therapeutic agents |
| EP0363085A3 (fr) * | 1988-10-03 | 1991-03-27 | Beecham Group Plc | Composés chimiques |
| CA2000041A1 (fr) * | 1988-10-13 | 1990-04-13 | Barry S. Orlek | Composes |
| GB8830226D0 (en) * | 1988-12-23 | 1989-02-22 | Beecham Group Plc | Novel compounds |
| IT1229491B (it) * | 1988-12-28 | 1991-09-03 | Roussel Maestretti S P A Ora R | Derivati della 1,2,5,6-tetraidropiridina, loro procedimento di preparazione e loro impiego come sostanze medicinali |
| US5106853A (en) * | 1989-05-15 | 1992-04-21 | Merck Sharp & Dohme, Ltd. | Oxadiazole and its salts, their use in treating dementia |
| GB8911080D0 (en) * | 1989-05-15 | 1989-06-28 | Merck Sharp & Dohme | Chemical process |
| US5075317A (en) * | 1989-06-21 | 1991-12-24 | Fisons Corporation | Spirofurane derivatives |
| GB8918060D0 (en) * | 1989-08-08 | 1989-09-20 | Merck Sharp & Dohme | Therapeutic agents |
| US5177084A (en) * | 1989-08-08 | 1993-01-05 | Merck Sharp & Dohme Ltd. | Therapeutic use of substituted benzenes, formulations thereof and novel substituted benzenes |
| GB8918061D0 (en) * | 1989-08-08 | 1989-09-20 | Merck Sharp & Dohme | Therapeutic agents |
| EP0412798A3 (en) * | 1989-08-08 | 1992-07-01 | Merck Sharp & Dohme Ltd. | Substituted pyridines, their preparation, formulations and use in dementia |
| EP0413545B1 (fr) * | 1989-08-16 | 1997-05-14 | Beecham Group Plc | Composés azabicycliques |
| DE69026197T2 (de) * | 1989-10-07 | 1997-01-09 | Beecham Group Plc | Azabizyklische Verbindungen, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen |
| US5407938A (en) * | 1990-04-10 | 1995-04-18 | Israel Institute For Biological Research | Certain 1-methyl-piperidine-4-spiro-4'-(1'-3'-oxazolines) and corresponding -(1',3' thiazolines) |
| EP0456310A3 (en) * | 1990-05-09 | 1992-03-04 | Merck Sharp & Dohme Ltd. | Enantioselective synthesis of 3-substituted 1-azabicyclo (2.2.1)heptanes |
| DE69102816T2 (de) * | 1990-05-11 | 1995-03-16 | Sankyo Co | Piperdinyloxy- und Chinindidinyloxy- isoxazol- Derivate, ihre Herstellung und ihre therapeutische Verwendung. |
| EP0459568A3 (en) * | 1990-05-31 | 1992-09-30 | Merck Sharp & Dohme Ltd. | Substituted oxadiazoles and thiadiazoles for use in the treatment of glaucoma and novel compounds having such use |
| IE912760A1 (en) * | 1990-08-06 | 1992-02-12 | Smith Kline French Lab | Compounds |
| US5527813A (en) * | 1990-08-21 | 1996-06-18 | Novo Nordisk A/S | Heterocyclic compounds and their preparation and use |
| DK198390D0 (da) * | 1990-08-21 | 1990-08-21 | Novo Nordisk As | Heterocykliske forbindelser, deres fremstilling og anvendelse |
| DK198490D0 (da) * | 1990-08-21 | 1990-08-21 | Novo Nordisk As | Heterocykliske forbindelser, deres fremstilling og anvendelse |
| US5376668A (en) * | 1990-08-21 | 1994-12-27 | Novo Nordisk A/S | Heterocyclic compounds |
| US5418240A (en) * | 1990-08-21 | 1995-05-23 | Novo Nordisk A/S | Heterocyclic compounds and their preparation and use |
| USRE35822E (en) * | 1990-08-21 | 1998-06-09 | Novo Nordisk A/S | Heterocyclic compounds |
| DK198590D0 (da) * | 1990-08-21 | 1990-08-21 | Novo Nordisk As | Heterocykliske forbindelser, deres fremstilling og anvendelse |
| CA2050264A1 (fr) * | 1990-08-30 | 1992-03-01 | Raymond Baker | Pyrazine a substitution et ses sels, compositions qui en contiennent et leur utilite en medecine |
| US5124460A (en) * | 1991-05-06 | 1992-06-23 | Merck Sharp & Dohme Ltd. | Enantioselective synthesis of 3-substituted 1-azabicyclo (2.2.1)heptanes |
| IE922270A1 (en) * | 1991-07-26 | 1993-01-27 | Akzo Nv | Pyrazole derivatives |
| US5641791A (en) * | 1991-08-13 | 1997-06-24 | Novo Nordisk A.S | Heterocyclic compounds and their preparation and use |
| EP0619814A1 (fr) * | 1991-12-31 | 1994-10-19 | Fujisawa Pharmaceutical Co., Ltd. | Derives d'oxadiazole a effet inhibiteur de l'acetylcholinesterase et agoniste muscarinique |
| WO1993014089A1 (fr) * | 1992-01-13 | 1993-07-22 | Novo Nordisk A/S | Composes heterocycliques, leur preparation et leur utilisation |
| US5244906A (en) * | 1992-01-23 | 1993-09-14 | Dowelanco | Insect control with substituted oxadiazole and thiadiazole compounds |
| TW214545B (fr) * | 1992-02-17 | 1993-10-11 | Ciba Geigy Ag | |
| AU672644B2 (en) * | 1992-12-23 | 1996-10-10 | Neurosearch A/S | Aryl substituted heterocyclic compounds |
| AU672052B2 (en) * | 1992-12-23 | 1996-09-19 | Neurosearch A/S | Antidepressant and antiparkinsonian compounds |
| AU671163B2 (en) * | 1992-12-23 | 1996-08-15 | Neurosearch A/S | Alkyl substituted heterocyclic compounds |
| US5393767A (en) * | 1993-08-26 | 1995-02-28 | Dowelanco | Insect control with substituted triazole and tetrazole compounds |
| US5612351A (en) * | 1994-11-08 | 1997-03-18 | Novo Nordisk A/S | Method of treating urinary bladder dysfunctions |
| GB9507203D0 (en) * | 1995-04-07 | 1995-05-31 | Smithkline Beecham Plc | Novel compounds |
| AU1141497A (en) * | 1995-11-29 | 1997-06-19 | Eli Lilly And Company | Heterocyclic compounds and their use |
| US5889019A (en) * | 1995-11-29 | 1999-03-30 | Eli Lilly And Company | Heterocyclic compounds and their use |
| GB9603755D0 (en) * | 1996-02-22 | 1996-04-24 | Pfizer Ltd | Therapeutic agents |
| US5834458A (en) * | 1996-10-09 | 1998-11-10 | Eli Lilly And Company | Heterocyclic compounds and their use |
| US5733912A (en) * | 1997-02-19 | 1998-03-31 | Abbott Laboratories | 7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission |
| US6107313A (en) * | 1998-10-02 | 2000-08-22 | Combichem, Inc. | Dopamine receptor antagonists |
| EP1315493A4 (fr) * | 2000-08-21 | 2007-12-05 | Univ Georgetown | Quinuclidines 2-3-disubstituees servant de modulateurs de transporteur de monoamine et procedes therapeutiques et diagnostiques se basant sur celles-ci |
| US7332508B2 (en) | 2002-12-18 | 2008-02-19 | Novo Nordisk A/S | Substituted homopiperidine, piperidine or pyrrolidine derivatives |
| EP2258746A2 (fr) | 2003-03-05 | 2010-12-08 | Toray Industries, Inc. | Polymère aromatique, film, membrane électrolytique et séparateur. |
| WO2005037832A2 (fr) | 2003-10-15 | 2005-04-28 | Targacept, Inc. | Compositions pharmaceutiques et methodes destinees au soulagement de la douleur et au traitement de troubles du systeme nerveux central |
| US8084473B2 (en) | 2007-04-24 | 2011-12-27 | Solvay Pharmaceuticals B.V. | Heterocyclic compounds with affinity to muscarinic receptors |
| WO2009140483A1 (fr) | 2008-05-15 | 2009-11-19 | University Of Toledo | Agonistes muscariniques servant de stimulateurs cognitifs |
| SG10201510665WA (en) * | 2009-12-04 | 2016-01-28 | Sunovion Pharmaceuticals Inc | Multicycle Compounds And Pharmaceutical Compositions Useful For The Treatment Of Neurological Disorders |
| US9549928B2 (en) | 2011-04-29 | 2017-01-24 | The University Of Toledo | Muscarinic agonists as enhancers of cognitive flexibility |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1053085A (fr) * | 1964-03-26 | |||
| JPS51143050U (fr) * | 1975-05-14 | 1976-11-17 | ||
| JPS5811948Y2 (ja) * | 1982-02-25 | 1983-03-07 | 日清紡績株式会社 | ブレ−キシユ−引込用スプリング装置 |
| GB8314391D0 (en) * | 1983-05-24 | 1983-06-29 | Kefalas As | Heterocyclic compounds |
| JPS6075732U (ja) * | 1983-10-31 | 1985-05-27 | シャープ株式会社 | ばね掛け装置 |
| JPS6191185A (ja) * | 1984-10-11 | 1986-05-09 | Sumitomo Seiyaku Kk | 新規なオキサジアゾリル−１，４−ジヒドロピリジン誘導体 |
| US4599344A (en) * | 1984-10-31 | 1986-07-08 | Schering A.G. | Quinuclidines and quinuclidinium salts as antiarrhythmic agents |
| ES2061502T3 (es) * | 1986-06-27 | 1994-12-16 | Beecham Group Plc | Nuevos n-heterociclos biciclicos puenteados. |
| IL83275A (en) * | 1986-09-08 | 1994-02-27 | Novo Nordisk As | Substituted 1, 2, 4- oxadiazolyl piperidine compounds, their preparation and pharmaceutical compositions containing them |
| AU614513B2 (en) * | 1987-04-15 | 1991-09-05 | Beecham Group Plc | 1-azabicyclic compounds |
| GB8808926D0 (en) * | 1988-04-15 | 1988-05-18 | Beecham Group Plc | Novel compounds |
| EP0413545B1 (fr) * | 1989-08-16 | 1997-05-14 | Beecham Group Plc | Composés azabicycliques |
-
1987
- 1987-03-17 NZ NZ219646A patent/NZ219646A/en unknown
- 1987-03-18 EP EP87302296A patent/EP0239309B1/fr not_active Expired - Lifetime
- 1987-03-18 DE DE3788739T patent/DE3788739T2/de not_active Expired - Fee Related
- 1987-03-18 IL IL81930A patent/IL81930A0/xx not_active IP Right Cessation
- 1987-03-18 ES ES87302296T patent/ES2061489T3/es not_active Expired - Lifetime
- 1987-03-19 US US07/027,989 patent/US5686463A/en not_active Expired - Fee Related
- 1987-03-20 PT PT84533A patent/PT84533B/pt not_active IP Right Cessation
- 1987-03-26 FI FI871325A patent/FI871325A7/fi not_active Application Discontinuation
- 1987-03-26 YU YU53587A patent/YU46688B/sh unknown
- 1987-03-26 AU AU70686/87A patent/AU603564B2/en not_active Ceased
- 1987-03-26 NO NO871277A patent/NO169439C/no unknown
- 1987-03-26 HU HU871324A patent/HUT51617A/hu unknown
- 1987-03-26 KR KR870002773A patent/KR870008883A/ko not_active Ceased
- 1987-03-26 DK DK154287A patent/DK154287A/da not_active Application Discontinuation
- 1987-03-27 JP JP62071952A patent/JPH0784466B2/ja not_active Expired - Lifetime
- 1987-03-27 CN CN198787102972A patent/CN87102972A/zh active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4837241A (en) * | 1986-09-08 | 1989-06-06 | A/S Ferrosan | Lipophillically-substituted piperidine oxadiazolyl compounds and their use in stimulating cognitive functions |
| US4933353A (en) * | 1986-09-08 | 1990-06-12 | A/S Ferrosan | Lipophilically-substituted piperidine oxadiazolyl compounds and their use in stimulating cognitive functions (II) |
| US5043345A (en) * | 1989-02-22 | 1991-08-27 | Novo Nordisk A/S | Piperidine compounds and their preparation and use |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6317879A (ja) | 1988-01-25 |
| NO169439C (no) | 1992-06-24 |
| AU603564B2 (en) | 1990-11-22 |
| NO871277D0 (no) | 1987-03-26 |
| PT84533B (pt) | 1989-11-10 |
| FI871325A7 (fi) | 1987-09-28 |
| JPH0784466B2 (ja) | 1995-09-13 |
| CN87102972A (zh) | 1987-11-18 |
| YU46688B (sh) | 1994-04-05 |
| YU53587A (en) | 1988-08-31 |
| DE3788739D1 (de) | 1994-02-24 |
| NO169439B (no) | 1992-03-16 |
| EP0239309A2 (fr) | 1987-09-30 |
| EP0239309A3 (en) | 1988-11-30 |
| EP0239309B1 (fr) | 1994-01-12 |
| DK154287D0 (da) | 1987-03-26 |
| KR870008883A (ko) | 1987-10-21 |
| FI871325A0 (fi) | 1987-03-26 |
| US5686463A (en) | 1997-11-11 |
| HUT51617A (en) | 1990-05-28 |
| ES2061489T3 (es) | 1994-12-16 |
| NZ219646A (en) | 1990-10-26 |
| IL81930A0 (en) | 1987-10-20 |
| DE3788739T2 (de) | 1994-07-14 |
| AU7068687A (en) | 1987-10-01 |
| PT84533A (en) | 1987-04-01 |
| NO871277L (no) | 1987-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK154287D0 (da) | Substituerede oxadiazol-derivater, fremgangsmaade til fremstilling deraf og mellemprodukter til brug ved fremgangsmaaden samt laegemiddel indeholdende oxadiazolerne | |
| NO871408D0 (no) | Forbedringer ved farmasoeytiske akseptable salter. | |
| FI871041A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 3,5-disubstituoitujen pyrokatekolijohdannaisten valmistamiseksi | |
| DK345488D0 (da) | Azolylmethyl-cyclopropyl-derivater, fremgangsmaader og mellemprodukter til deres fremstilling samt deres anvendelse | |
| NO885106D0 (no) | Fremgangsmte ved fremstilling av cytidin-derivater. | |
| NO894786L (no) | Fremgangsmaate for fremstilling av propenonoksimetere. | |
| DK333083D0 (da) | 2-aza-bicyclo(2.2.2)octan-3-carboxylsyrederivater, deres fremstilling og anvendelse samt ved fremstillingen anvendelige mellemprodukter og disses fremstilling | |
| NO880068L (no) | Fremgangsmaate ved fremstilling av heteroaryl-3-okso-propannitrilderivater. | |
| DK528889D0 (da) | Substituerede quinolinderivater og fremgangsmaade til fremstilling deraf, mellemprodukter til anvendelse ved deres fremstilling og farmaceutiske midler indeholdende derivaterne | |
| DK300688A (da) | Heterocycliske hydroxyethylazolderivater, fremgangsmaader og mellemprodukter til deres fremstilling samt deres anvendelse | |
| NO880473L (no) | Fremgangsmaate til fremstilling av substituerte 3,4-dihydro-2h-benzopyraner og deres anvendelse som legemiddel. | |
| NO803881L (no) | Nye derivater av 2-(4-piperidyl)-1-(4-kinolyl)-etanon, samt mellomprodukter for, og fremstilling og bruk av medikamenter | |
| NO883833L (no) | Fremgangsmaate for fremstilling av isoxazol-betacarbolinderivater. | |
| DK567188A (da) | 2,2-dimethylchromenderivater og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende derivaterne | |
| DK416888D0 (da) | Cephalosporinforbindelser, krystallinske derivater deraf, mellemprodukter til brug ved fremstilling af cephalosporinforbindelser og fremgangsmaader til fremstilling af cephalosporinforbindelser | |
| NO872158D0 (no) | Fremgangsmaate ved fremstilling av nye aromatiske naftylderivater. | |
| FI882165A7 (fi) | Menetelmä 4-amino-androsteenidioni-johdannaisten valmistamiseksi. | |
| DK425788D0 (da) | 1,4-disubstituerede 1-azolyl-3,3-dimethylbutanderivater, fremgangsmaade til deres anvendelse samt deres anvendelse | |
| NO882528D0 (no) | Fremgangsmaate ved fremstilling av 2-metoksymetyl-penem-derivater. | |
| DK612886A (da) | Substituerede ortho-anisamider, fremgangsmaade til fremstilling deraf og mellemprodukter til brug ved fremgangsmaaden samt laegemidler indeholdende anisamiderne | |
| NO884600D0 (no) | Fremgangsmaate ved fremstilling av et roerformet legeme. | |
| DK639888A (da) | 3-aminopyrazolin-5-oner, fremgangsmaader og mellemprodukter til deres fremstilling samt deres anvendelse | |
| DK439588D0 (da) | Beta-lactamer, fremgangsmaade til deres fremstilling, mellemprodukter til brug derved og farmaceutiske praeparater indeholdende forbindelserne | |
| DK439789A (da) | Ethansulfonamidforbindelser, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater indeholdende samme samt mellemprodukter til anvendelse ved fremgangsmaaden | |
| DK631386D0 (da) | 1-carbacephalosporin-antibiotika, fremgangsmaade til fremstilling deraf samt mellemprodukter til brug ved fremgangsmaaden |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed | ||
| AHS | Application shelved for other reasons than non-payment |